150 related articles for article (PubMed ID: 19487150)
1. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?
Barut S; Dincer F; Sahin I; Ozyurt H; Akkus M; Erkorkmaz U
Int J Infect Dis; 2010 Jan; 14(1):e50-4. PubMed ID: 19487150
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
4. Cytokine levels in Crimean-Congo hemorrhagic fever.
Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A
J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
8. C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever.
Turkdogan KA; Zorlu A; Engin A; Guven FM; Polat MM; Turgut OO; Yilmaz MB
Int J Infect Dis; 2012 Aug; 16(8):e616-20. PubMed ID: 22695238
[TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
[TBL] [Abstract][Full Text] [Related]
10. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
12. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
[TBL] [Abstract][Full Text] [Related]
14. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.
Bodur H; Akinci E; Ongürü P; Uyar Y; Baştürk B; Gözel MG; Kayaaslan BU
Int J Infect Dis; 2010 Aug; 14(8):e704-7. PubMed ID: 20627646
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
16. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever.
Sonmez M; Aydin K; Durmus A; Sucu N; Yilmaz M; Akdogan E; Koksal I; Ovali E; Omay SB
J Infect; 2007 Aug; 55(2):184-7. PubMed ID: 17418898
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A
J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
[TBL] [Abstract][Full Text] [Related]
19. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
20. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever.
Bakir M; Engin A; Gozel MG; Elaldi N; Kilickap S; Cinar Z
J Vector Borne Dis; 2012 Jun; 49(2):105-10. PubMed ID: 22898483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]